🧮
home/
calculators/
health/
cha2ds2 vasc score calculator

CHA₂DS₂‑VASc Score Calculator – Atrial Fibrillation Stroke Risk

CHA₂DS₂‑VASc Score

The CHA₂DS₂‑VASc Score Calculator is a validated clinical tool used to estimate the annual stroke risk in patients with non‑valvular atrial fibrillation (AFib). It guides physicians and patients in deciding whether to initiate oral anticoagulation therapy (e.g., warfarin, apixaban, rivaroxaban, dabigatran). A higher score indicates greater stroke risk, and a score ≥2 generally warrants anticoagulation. This calculator is essential for cardiologists, general practitioners, internists, and medical students.

CHA₂DS₂‑VASc Score ComponentsC: Heart failure (1) | H: Hypertension (1)A₂: Age ≥75 (2) | A₁: Age 65‑74 (1)D: Diabetes (1) | S₂: Prior Stroke/TIA (2)V: Vascular disease (1) | Sc: Female sex (1)Score ≥2 → Oral anticoagulation indicated

CHA₂DS₂‑VASc Score Components

C – Congestive heart failure (1 point)

H – Hypertension (1 point)

A₂ – Age ≥75 years (2 points)

A₁ – Age 65–74 years (1 point)

D – Diabetes mellitus (1 point)

S₂ – Prior stroke/TIA/thromboembolism (2 points)

V – Vascular disease (prior MI, PAD, aortic plaque) (1 point)

Sc – Sex category (female) (1 point)

How to Use This CHA₂DS₂‑VASc Calculator

  1. Check all boxes that apply to the patient.
  2. Note that age categories are mutually exclusive (≥75 overrides 65‑74).
  3. Click “Calculate Score” to see the total score, risk category, and treatment recommendation.

Why This Score Matters in Clinical Practice

CHA₂DS₂‑VASc Score & Adjusted Annual Stroke Risk Reference Table

CHA₂DS₂-VASc ScoreAnnual Stroke Risk %Risk StratificationESC/AHA Guideline Recommendation
0 Points0.2%Low RiskNo antithrombotic therapy required
1 Point0.6% – 1.3%Low-Moderate RiskConsider DOAC based on individual clinical assessment
2 Points2.2%Moderate-High RiskOral Anticoagulation (DOAC/Warfarin) strongly recommended
3 Points3.2%High RiskOral Anticoagulation strongly indicated
4 Points4.0%High RiskOral Anticoagulation strongly indicated
5 Points6.7%Very High RiskOral Anticoagulation strongly indicated
6 Points9.8%Very High RiskOral Anticoagulation strongly indicated
7–9 Points9.6% – 12.2%+Severe RiskOral Anticoagulation mandatory unless absolute contraindication

Clinical Evidence & Guidelines for CHA₂DS₂‑VASc

The CHA₂DS₂‑VASc score evolved from the earlier CHADS₂ score to better identify truly low‑risk patients. In a meta‑analysis, the annual stroke rate without anticoagulation ranged from 0.2% (score 0) to over 9% (score 6+). The ESC 2020 AF guidelines recommend oral anticoagulation for all patients with a CHA₂DS₂‑VASc score ≥2 in men and ≥3 in women (though practical thresholds are often ≥2 for both). This calculator uses the conservative threshold of ≥2 for high risk.

Limitations: The score does not account for labile INR (if on warfarin), falls risk, or patient preference. Always combine with a bleeding risk score (HAS‑BLED) before initiating anticoagulation. Also, note that vascular disease includes prior myocardial infarction, peripheral artery disease, or complex aortic plaque. The “Sc” (female sex) component is controversial; women under 65 with no other risk factors have low risk, so guidelines often treat them as low risk.

Practical use in clinic: Take a thorough history to document each component. For example, heart failure may be evidenced by previous hospitalisation or LVEF <40%. Hypertension is present if the patient is on antihypertensive medication or has documented BP greater than 140/90. Diabetes is diagnosed according to standard criteria. Prior stroke/TIA should be confirmed by medical records. Use this CHA₂DS₂‑VASc risk calculator at every AFib patient encounter to reassess risk as patients age or develop new comorbidities.

Bookmark this stroke risk calculator for atrial fibrillation for quick reference. It is a free, educational tool designed for healthcare professionals. For individual patient management, always consider the full clinical picture and consult a specialist.

Step‑by‑Step Manual Example

Patient: 72‑year‑old female with hypertension, diabetes, prior TIA

C: no → 0, H: yes → +1, A₂: age ≥75? No (72) → 0, A₁: 65‑74 → +1, D: yes → +1, S₂: prior TIA → +2, V: no → 0, Sc: female → +1.

Total = 1+1+1+2+1 = 6 → High risk → oral anticoagulation indicated.

Frequently Asked Questions about CHA₂DS₂‑VASc Score

What is the CHA₂DS₂-VASc score?
The CHA₂DS₂-VASc score is a clinical risk stratification tool used to estimate the annual risk of ischemic stroke and systemic embolism in patients with non-valvular atrial fibrillation (AFib).
What do the letters in CHA₂DS₂-VASc stand for?
C = Congestive Heart Failure (+1), H = Hypertension (+1), A₂ = Age ≥75 (+2), D = Diabetes (+1), S₂ = Stroke/TIA (+2), V = Vascular Disease (+1), A₁ = Age 65–74 (+1), Sc = Sex Category female (+1).
At what score should oral anticoagulation (OAC) be started?
According to ESC and AHA guidelines: Score 0 (men) / 1 (women) = No anticoagulation. Score 1 (men) = Consider OAC. Score ≥2 (men or women) = Oral Anticoagulation (DOAC preferred over Warfarin) is strongly recommended.
What is the annual stroke risk for a score of 0 vs score of 9?
A score of 0 carries an estimated annual stroke risk of 0.2%, whereas a maximum score of 9 carries an annual stroke risk exceeding 12.2% without anticoagulation.
Why are DOACs preferred over Warfarin for AFib?
Direct Oral Anticoagulants (DOACs like apixaban, rivaroxaban, dabigatran, edoxaban) have lower rates of intracranial hemorrhage and fixed dosing without routine INR blood testing.
Can CHA₂DS₂-VASc be used for valvular atrial fibrillation?
No. Valvular AFib (moderate-to-severe mitral stenosis or mechanical heart valves) automatically requires Warfarin anticoagulation regardless of the CHA₂DS₂-VASc score.
How does HAS-BLED relate to CHA₂DS₂-VASc?
CHA₂DS₂-VASc assesses stroke risk (benefit of anticoagulation), while HAS-BLED assesses major bleeding risk. A high HAS-BLED score should prompt modifiable risk factor correction, not withholding anticoagulation.
Is female sex alone an independent risk factor for stroke?
Female sex is a risk modifier that accentuates stroke risk when other risk factors are present. Women under 65 with AFib and no other risk factors (score 1 for sex only) do not require anticoagulation.